IFNG and neoplasm: Given the importance of the IFNγ signaling pathway in colorectal cancer immunity and that dysfunctional IFNγ signaling in tumor cells is a mechanism of immunotherapy resistance, it is critical to study the kinetic changes in the IFNγ signaling pathway during the course of ICB in patients with colorectal cancer.